Recruiting

SPeCTRuMDiabetes Complication Prevalence in Cystic Fibrosis

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected at a single point in time - Cross-sectional
DNA Samples
Who is being recruted

Urogenital Diseases+19

+ Cystic Fibrosis

+ Diabetes Mellitus

Over 12 Years
+15 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: September 2025
See protocol details

Summary

Principal SponsorJaeb Center for Health Research
Study ContactJudy Sibayan, MPH, CCRPMore contacts
Last updated: February 11, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: September 18, 2025

Actual date on which the first participant was enrolled.

This study, called SPeCTRuM, focuses on adolescents and adults with a condition known as Cystic Fibrosis (CF), and more specifically, those who also have Cystic Fibrosis Related Diabetes (CFRD). The main goal is to understand the prevalence of diabetes-related complications in this diverse group of individuals. The study aims to shed light on how these complications might be linked to factors like blood sugar levels, diabetes duration, and body mass index. This research holds importance as it could pave the way for improved care and management strategies for those living with both CF and CFRD.

Official TitleStudying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
NCT06837181
Principal SponsorJaeb Center for Health Research
Study ContactJudy Sibayan, MPH, CCRPMore contacts
Last updated: February 11, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

200 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 12 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesCystic FibrosisDiabetes MellitusDigestive System DiseasesEndocrine System DiseasesEye DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsInfant, Newborn, DiseasesKidney DiseasesLung DiseasesMetabolic DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNutritional and Metabolic DiseasesPancreatic DiseasesRespiratory Tract DiseasesRetinal DiseasesUrologic DiseasesGenetic Diseases, InbornGlucose Metabolism DisordersDiabetes ComplicationsFemale Urogenital DiseasesMale Urogenital Diseases

Criteria

6 inclusion criteria required to participate
Written informed consent (and assent when applicable) obtained from participant or participant's legally authorized representative
For Adults: Must be able to consent on one own's behalf (i.e., cannot lack cognitive capacity to consent due to the required patient-reported outcomes)
Be willing and able to adhere to the study protocol requirements
Age ≥ 12 years at time of enrollment
Show More Criteria
9 exclusion criteria prevent from participating
Peripheral artery disease or leg artery disease
Erratic, accelerated or mechanically controlled irregular heart rhythms including arrhythmias
Carotid or aortic valve stenosis
Generalized constriction or localized spasm of muscular conduit arteries such as seen immediately after hypothermic cardiopulmonary bypass surgery or accompanying Raynaud's phenomena or intense cold.
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 18 locations

Recruiting

University of Colorado Denver

Aurora, United StatesOpen University of Colorado Denver in Google Maps
Recruiting

Emory University School of Medicine

Atlanta, United States
Recruiting

University of Minnesota

Minneapolis, United States
Recruiting

The Children's Hospital of Philadelphia

Philadelphia, United States
Recruiting
18 Study Centers
SPeCTRuM | Diabetes Complication Prevalence in Cystic Fibrosis | PatLynk